Abstract: This paper presents a structured and critical syn-thesis of methods, metrics, technologies, and evidence for im-proving power grid reliability and ...

HOUSTON — We're tracking a flooding threat all week as tropical moisture moves into the Houston area. Flooding in Houston can cause big problems on the road. You can lose control or stall in less than ...

Drew Dirksen tests how long he can survive underwater in an endurance challenge.

Deep beneath the ocean's surface, engineers have created one of the most extraordinary construction projects ever imagined. Building a tunnel underwater is already a massive challenge—but constructing ...

An Instagram video sparked debate after a doctor and mother said fans at a World Cup match in Santa Clara, California, were left waiting in long lines for water during a heat advisory. The video, ...

Madrigal Pharmaceuticals made history in 2024 when it earned approval for Rezdiffra, the first medicine for metabolic dysfunction-associated steatohepatitis (MASH). There was a dire need for a ...

Netflix (NFLX) sits 39% off its all-time high as ad revenue heads toward $3 billion in 2026 and analysts target $114 a share. Since April earnings NFLX dropped 25% while SPY gained 4%, with 10-year ...

China reacts after Trump announces deal to end Iran war President Donald Trump's 7-word take on interest rates is due for a reality check Pope Leo XIV warns that AI must be disarmed and cites Gandalf ...

The Federal Reserve is almost certainly going to do nothing at its June 16-17 meeting. Markets are pricing in a 96% probability that the Fed holds its benchmark ...

The Detroit Lions defense is looking for notable improvement in year two. They might get improved health and better play from the roster, but Dan Campbell expects a much better defensive coordinator ...

NEW YORK--(BUSINESS WIRE)--Freedom Holding Corp. (Nasdaq: FRHC), an international financial technology group, today announced that it has launched an offering of its common stock for aggregate amount ...

AbbVie Inc. has successfully replaced Humira's lost revenue with Skyrizi and Rinvoq, now exceeding Humira’s peak sales. AbbVie trades at a forward P/E of 14.8x, below the pharma peer average, with ...